{'fraction_non_alphanumeric': 0.018518518518518517, 'fraction_numerical': 0.004273504273504274, 'mean_word_length': 5.166666666666667, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Cost Containment in Infection Control: DRGs and Outpatient Antibiotics

The advent of a non-cost reimbursement system has served as an impetus for the re-examination of the methods by which infectious processes are treated. This system prospectively sets payment rates for illnesses that require hospitalization. Diagnostic-Related Groups (DRGs) are the basis of this new system. DRGs attempt to link reimbursement to the broad category of clinical diagnosis by separating diagnoses into nearly 500 groups; each with a defined reimbursement rate. This rate does not substantially vary with regard to the length of hospital stay, the number of diagnostic tests performed or the cost of therapy employed.